Hepatocyte growth factor promotes liver regeneration with prompt improvement of hyperbilirubinemia in hepatectomized cholestatic rats

Journal of Surgical Research

Volumn 78, Issue 1, 1998, Pages 54-59

  Yoshikawa, Akira ^a   Kaido, Toshimi ^a   Seto, Shin Ichi ^a   Yamaoka, Shoji ^a   Sato, Maki ^b   Ishii, Takehisa ^b   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

Cholestasis; Hepatectomy; Hyperbilirubinemia; Liver regeneration

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; RECOMBINANT SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; DRUG SCREENING; HYPERBILIRUBINEMIA; INTRAHEPATIC CHOLESTASIS; JAUNDICE; LIVER REGENERATION; LIVER RESECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032527501     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5350     Document Type: Article

References (33)

1. Nakamura, T., Nawa, K., and Ichihara, A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122: 1450, 1984.
2. Russell, W. E., McGowan, J. A., and Bucher, N. L. Partial characterization of a hepatocyte growth factor from rat platelets. J. Cell Physiol. 119: 183, 1984.
3. Matsumoto, K., and Nakamura, T. Hepatocyte growth factor: Molecular structure, roles in liver regeneration and other biological functions. Crit. Review Oncog. 3: 27, 1992.
4. Rubin, J. S., Bottaro, D. P., and Aaronso, S. A. Hepatocyte growth factor/scatter factor and its receptor, the c-met protooncogene product. Biochim. Biophy. Acta 1155: 357, 1993.
5. Fujiwara, K., Nagoshi, S., Ohno, A., Hirata, K., Ohta, Y., Mochida, S., Tomiya, T., Higashio, K., and Kurokawa, K. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 18: 1443, 1993.
6. Ishii, T., Sato, M., Sudo, K., Suzuki, M., Nakai, H., Hishida, T., Niwa, T., Umezu, K., and Yuasa, S. Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J. Biochem. Tokyo 117: 1105, 1995.
7. Yasuda, H., Imai, E., Shiota, A., Fujise, N., Morinaga, T., and Higashio, K. Antifibrotic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rats. Hepatology 24: 636, 1996.
8. Matsuda, Y., Matsumoto, K., Ichida, T., and Nakamura, T. Hepatocyte growth factor suppresses the onset of liver cirrhosis and ablogates lethal hepatic dysfunction in rats. J. Biochem. Tokyo 118: 643, 1995.
9. Kaido, T., Seto, S., Yamaoka, S., Yoshikawa, A., and Imamura, M. Perioperative continuous hepatocyte growth factor supply prevents postoperative liver failure in rats with liver cirrhosis. J. Surg. Res., in press.
10. Ishiki, Y., Ohnishi, H., Muto, Y., Matsumoto, K., and Nakamura, T. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent anti-hepatitis effect in vivo. Hepatology 16: 1227, 1992.
11. 4-induced acute liver injury in rats. Biochem. Biophys. Res. Commun. 218: 1, 1996.
12. Kaido, T., Yamaoka, S., Seto, S., Tanaka, J., Funaki, N., Nakamura, T., and Imamura, M. Continuous hepatocyte growth factor supply prevents lipopolysaccharide-induced liver injury in rats. FEBS Lett. 411: 378, 1997.
13. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann. Surg. 211: 277, 1990.
14. Nagasue, N., Yukaya, H., Ogawa, Y., Kohno, H., and Nakamura, T. Human liver regeneration after major hepatic resection: A study of normal liver and livers with chronic hepatitis and cirrhosis. Ann. Surg. 206: 30, 1987.
15. Raoul, P., Yves, C., Renee, E. P., Francois, B., Yvon, C., and Francois, D. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet 11: 834, 1987.
16. Hofmann, A. F. Ursodeoxycholic acid for primary biliary cirrhosis. Lancet 11: 398, 1987.
17. Mitchison, H. C., Palmer, J. M., Bassendine, M. F., Watson, A. J., Record, C. O., and James, O. F. A controlled trial of prednisolone treatment in primary biliary cirrhosis. Three-year results. J. Hepatol. 15: 336, 1992.
18. Higgins, G. M., and Anderson, R. M. Experimental pathology of liver: Restoration of liver of the white rat following partial surgical removal. Arch. Pathol. 12: 186, 1931.
19. Yoshiyama, Y., Arakaki, N., Naka, D., Takahashi, K., Hirono, S., Kondo, J., Nakayama, H., Gohda, E., Kitamura, N., Tsubouchi, H., Ishii, T., Hishida, T., and Daikuhara, Y. Identification of the N-terminal residue of the heavy chain of both native and recombinant human hepatocyte growth factor. Biochem. Biophys. Res. Commun. 175: 660, 1991.
20. Panis, Y., McMullan, D. M., and Emond, J. C. Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery 121: 142, 1997.
21. Rai, R. M., Loffreda, S., Karp, C. L., Yang, S. Q., Lin, H. Z., and Diehl, A. M. Kupffer cell depletion abolishes induction of interleukin-10 and permits sustained overexpression of tumor necrosis factor alpha messenger RNA in the regenerating rat liver. Hepatology 25: 889, 1997.
22. Roos, F., Terrell, T. G., Godowski, P. J., Chamow, S. M., and Schwall, R. H. Reduction of α-naphthylisothiocyanate-induced hepatotoxicity by recombinant human hepatocyte growth factor. Endocrinology 131: 2540, 1992.
23. Schaffner, F., Scharnbeck, H.H., Hutterner, F., Denk, H., Greim, H. A., and Popper, H. Mechanism of cholestasis. VII. α-naphthylisothiocyanate-induced jaundice. Lab. Invest. 28: 321, 1973.
24. Goldfarb, S., Singer, E. J., and Popper, H. Experimental cholangitis due to alpha-naphthylisothiocyanate (ANIT). Am. J. Pathol. 40: 685, 1962.
25. Connolly, A. K., Price, S. C., Connelly, J. C., and Hinton, R. H. Early changes in bile duct lining cells and hepatocytes in rats treated with α-naphthylisothiocyanate. Toxicol. Appl. Pharmacol. 93: 208, 1988.
26. Desmet, V. J., Krstulovic, B., and Damme, B. Histochemical study of rat liver in alpha-naphthylisothiocyanate (ANIT)-induced cholestasis. Am. J. Pathol. 52: 401, 1968.
27. Jean, P. A., Bailie, M. B., and Roth, R. A. 1-naphthylisothiocyanate-induced elevation of biliary glutathione. Biochem. Pharmacol. 49: 197, 1995.
28. Fukumoto, Y., Okita, K., Kodama, T., Noda, K., Harada, Y., Mizuta, M., and Takemoto, T. Studies of alpha-naphthylisothiocyanate-induced hepatic disturbance. Hepato-Gastroenterology 27: 457, 1980.
29. Joplin, R., Hishida, T., Tsubouchi, H., Daikuhara, Y., Ayres, R., Neubergner, J. M., and Strain, A. J. Human intrahepatic biliary epithelial cells proliferate in vitro in response to human hepatocyte growth factor. J. Clin. Invest. 90: 1284, 1992.
30. Harbrecht, B. G., Di Silvio, M., Demetris, A. J., Simmons, R. L, and Billiar, T. R. Tumor necrosis factor-α regulates in vivo nitric oxide synthesis and induces liver injury during endotoxemia. Hepatology 20: 1055, 1994.
31. Mizuhara, H., Uno, M., Seki, N., Yamashita, M., Yamaoka, M., Ogawa, T., Kaneda, K., Fujii, T., Senoh, H., and Fujiwara, H. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 23: 1608, 1996.
32. Collart, M. A., Belin, D., Vassalli, J. D., de Kossodo, S., and Vassalli, P. γ-Interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J. Exp. Med. 164: 2113, 1986.
33. Morita, M., Watanabe, Y., and Akaike, T. Protective effect of hepatocyte growth factor on interferon-gamma-induced cytotoxicity in mouse hepatocytes. Hepatology 21: 1585, 1995.